Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1154 for “"HER2"”.

  1. Resistance to HER2-targeted therapies in HER2-positive breast cancer

    … and human epidermal growth factor receptor 2 (HER2). Historically, HER2-positive breast cancers had a worse survival prognosis than oestrogen or progesterone receptor-positive cancers, but the development of HER2-targeted therapies led to significant survival improvements. Despite this, …

    edinburgh Repository record for Resistance to HER2-targeted therapies in HER2-positive breast cancer (opens in a new tab)

  2. NOVEL HER2 MUTATIONS CONFER ENDOCRINE RESISTANCE IN ER+ HER2- BREAST CANCER

    … through tumor acquisition of one of four HER2 activating mutations, which also confers cross-resistance to other treatments for breast cancer (including CDK4/6 inhibitors). We hypothesized that the spectrum of HER2 mutations that confer endocrine resistance in breast cancer was larger than …

    jhu Repository record for NOVEL HER2 MUTATIONS CONFER ENDOCRINE RESISTANCE IN ER+ HER2- BREAST CANCER (opens in a new tab) Embargoed until 2028-05-01

  3. Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom

    … Bedeutung der ErbB-Wachstumsfaktoren EGFR und HER2 beim BTC wurde bereits seit Anfang der 90er Jahre erkannt, weshalb zu diesem Thema zahlreiche Veröffentlichungen erschienen sind. Die Ergebnisse dieser Arbeiten sind häufig different, was auf die teilweise kleinen Patientenkollektive sowie die …

    freiburg-diss Repository record for Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom (opens in a new tab)

  4. Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer

    … rates. Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20-30% of BC. HER2 overexpression is also observed in other cancers such as gastric/gastroesophageal, ovarian, lung, prostate, bladder, colon and head and neck. HER2-positive BC is characterized by aggressive disease and …

    sask Repository record for Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer (opens in a new tab)

  5. Modeling HER2 Mutations in Colorectal Cancer using a HER2 Transgenic Mouse Model and Gastrointestinal Organoids

    … epidermal growth factor receptor family, such as HER2, have been identified in several human diseases. In particular, mutations in the intracellular kinase domain have been identified in breast, colon, and lung cancers. The Cancer Genome Atlas has identified HER2 mutations or gene amplification in …

    wustl Repository record for Modeling HER2 Mutations in Colorectal Cancer using a HER2 Transgenic Mouse Model and Gastrointestinal Organoids (opens in a new tab)

  6. HER2-targeted Theranostic Radioimmunoconjugates for SPECT Imaging and α-particle Radioimmunotherapy of HER2-positive Breast Cancer

    The human epidermal growth factor receptor 2 (HER2) is overexpressed in 15–20% of breast cancer (BC) patients. HER2-targeting antibody trastuzumab IgG and its smaller molecular weight fragments trastuzumab F(ab′)2 and Fab were modified with the metal chelator 1,4,7,10-tetraazacyclododecane-1,4,7,10 …

    toronto-retro Repository record for HER2-targeted Theranostic Radioimmunoconjugates for SPECT Imaging and α-particle Radioimmunotherapy of HER2-positive Breast Cancer (opens in a new tab)

  7. Tandem Peptides Targeting HER2 for Delivery of CD44 siRNA into HER2+ Breast Cancer Cells in Vitro

    … year due to the disease in the United States. HER2+ breast cancer accounts for 20-25% of invasive breast cancer, and it has a worse prognosis and higher early-stage mortality rate than other breast cancer subtypes. Common treatments for HER2+ breast cancer involve surgical removal of the breast …

    clemson Repository record for Tandem Peptides Targeting HER2 for Delivery of CD44 siRNA into HER2+ Breast Cancer Cells in Vitro (opens in a new tab)

  8. Kombinatorische Effekte des HER2-spezifischen Tyrosinkinaseinhibitors Tucatinib mit Bestrahlung bei HER2-positiven humanen Mamma- und Kolorektalkarzinomzelllinien

    … sich mit den kombinatorischen Effekten des HER2-spezifischen Tyrosinkinaseinhibitors Tucatinib mit Bestrahlung bei HER2-positiven humanen Mamma- und Kolorektalkarzinomzelllinien.

    qucosa-diss

  9. HER2/neu-specific Breast Cancer Vaccine

    … percent have amplification of the self-antigen HER2/neu. Later studies demonstrated that HER2/neu-specific antibody and T cell responses were found in HER2/neu-positive breast cancer patients, indicating HER2/neu is a good target for active immunotherapy. A humanized anti HER2/neu antibody …

    sask Repository record for HER2/neu-specific Breast Cancer Vaccine (opens in a new tab)

  10. Strategies for HER2 Targeted PET Imaging

    … deadly cancers diagnosed in women each year. The HER2-positive subtype of breast cancer is associated with poor prognosis and lower progression-free survival. Early identification of HER2 expression is extremely important for the effective treatment of the disease. Current methods to diagnose …

    uab Repository record for Strategies for HER2 Targeted PET Imaging (opens in a new tab)

  11. Photoimmuntherapie des HER2-positiven Mamma-Karzinoms

    … eine cysteinmodifizierte Variante des Anti-HER2-Antikörpers Trastuzumab für die Photoimmuntherapie (PIT) des Mamma-Karzinoms an den Phthalocyanin-Farbstoff WB692-CB1 gekoppelt. Hierfür wurde eine cysteinmodifizierte Trastuzumab-Variante kloniert und in Expi293F-Zellen exprimiert und …

    freiburg-diss Repository record for Photoimmuntherapie des HER2-positiven Mamma-Karzinoms (opens in a new tab)

  12. Metabolic vulnerability in HER2-positive Breast Cancer

    … human epidermal growth factor receptor 2, or HER2, is overexpressed in 20-30% breast cancer patients and is associated with aggressive disease. Therapies targeting HER2, including monoclonal antibodies (trastuzumab and pertuzumab), a small molecule kinase inhibitor (lapatinib) and an …

    duke Repository record for Metabolic vulnerability in HER2-positive Breast Cancer (opens in a new tab)

  13. Ανοσοθεραπεία Her2/neu όγκων με ανασυνδυασμένα βιομόρια

    … of 4 transmembrane receptors: EGFR (ErbB1/Her1), Her2 (ErbB2), Her3 (ErbB3) and Her4 (ErbB4). These receptors are located in cells of epithelial origin, where their base-lateral placement allows them to intervene in the transfer of signals between mesenghyma and epithelium. These signals control …

    greece Repository record for Ανοσοθεραπεία Her2/neu όγκων με ανασυνδυασμένα βιομόρια (opens in a new tab)

  14. INVESTIGATION OF LIGAND SIZE ON TARGETED PLGA NANOPARTICLES FOR HER2 BREAST CANCER: TRASTUZUMAB AND ITS ScFv ANTI-HER2 ANTIBODY

    … human epidermal growth factor receptor-2 (HER2) specifically in breast cancer. Poly (D, L-lactide-co-glycolide) (PLGA) polymer, which is approved by FDA, was used to form nanoparticles (NPs) encapsulating docetaxel (DOC) as chemotherapy. HER2 antibody moieties, either whole IgG (TrAb) or …

    sask Repository record for INVESTIGATION OF LIGAND SIZE ON TARGETED PLGA NANOPARTICLES FOR HER2 BREAST CANCER: TRASTUZUMAB AND ITS ScFv ANTI-HER2 ANTIBODY (opens in a new tab)

  15. Assessing the effects of anti-HER2 treatments in combination with hormone treatment and immunotherapy in HER2-Low breast cancer

    … 15-20% of breast cancers are due to HER2 overexpression or gene amplification, which correlates with poor prognosis. The development of a monoclonal antibody, trastuzumab, directed against HER2 has improved the prognosis of HER2-positive breast cancers. However, due to ambiguities in …

    kings Repository record for Assessing the effects of anti-HER2 treatments in combination with hormone treatment and immunotherapy in HER2-Low breast cancer (opens in a new tab) Download PDF for Assessing the effects of anti-HER2 treatments in combination with hormone treatment and immunotherapy in HER2-Low breast cancer (opens in a new tab)

Page 1 of 58